[Association between HBV genotype and chronic/severe liver disease with HBV infection in Chinese patients]

Ai-Min Zhang1, Hui-Fen Wang, Hai-Bin Wang

  • 1Liver Failure Treatment and Research Center, 302nd Hospital of PLA, Beijing 100039, China.

Insights

Hepatitis B virus (HBV) genotype C is more frequently linked to severe liver disease, including cirrhosis and liver cancer, in Chinese patients compared to genotype B. However, genotype differences did not significantly impact acute-on-chronic liver failure occurrence.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Background:

  • Hepatitis B virus (HBV) infection remains a significant global health concern.
  • Understanding the influence of HBV genotypes on disease progression is crucial for effective management.

Purpose of the Study:

  • To investigate the association between HBV genotypes and the development of chronic and severe liver disease in a Chinese patient cohort.
  • To analyze the correlation between HBV genotypes and virological/biochemical markers of liver disease.

Main Methods:

  • Serum samples from 2922 HBV-infected Chinese patients were analyzed.
  • HBV genotyping was performed using type-specific primers polymerase chain reaction.
  • Virological markers, biochemical markers, and clinical classifications were assessed and compared across different HBV genotypes.

Main Results:

  • HBV genotypes B and C were predominant (15.9% and 83.5%, respectively).
  • Genotype C was significantly more prevalent in cirrhosis and hepatocellular carcinoma groups compared to genotype B.
  • HBeAg-positive rates and viral loads were higher in genotype C patients with severe liver disease (cirrhosis, hepatocellular carcinoma) compared to genotype B.

Conclusions:

  • HBV genotypes B and C are the main types in Chinese patients.
  • HBV genotype C is associated with a higher risk of chronic infection, cirrhosis, and hepatocellular carcinoma compared to genotype B.
  • While genotype did not significantly affect acute-on-chronic liver failure, genotype C infection correlated with more severe liver damage and higher viral loads in advanced disease stages.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...